staurosporine has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelstein, RS; Chen, L; Conti, MA; Kwan, R; Looi, K; Omary, MB; Snider, NT; Tao, GZ; Weerasinghe, SV; Xie, Q | 1 |
| Bohnekamp, J; Magin, TM | 1 |
2 other study(ies) available for staurosporine and Liver Dysfunction
| Article | Year |
|---|---|
PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.
Topics: Animals; Intermediate Filaments; Keratins; Liver Diseases; Mice; Mice, Transgenic; Mutation; Myosins; Protein Binding; Staurosporine | 2015 |
Small molecule targeting of a myosin partner restores an intact keratin cytoskeleton despite presence of a dominant keratin mutation.
Topics: Animals; Intermediate Filaments; Keratins; Liver Diseases; Mutation; Myosins; Staurosporine | 2015 |